MedTrace Logo

Transcutaneous CO2 Measurement - From Hospital to Home

NCT06694870 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2024-11-19

No results posted yet for this study

Summary

Long-term non-invasive ventilation (LT-NIV) is the main treatment modality for chronic hypercapnic respiratory failure.To assess the adequacy of alveolar ventilation during sleep and potential sleep hypoventilation, nocturnal transcutaneous CO2 (PtcCO2) monitoring is necessary. There is an increased tendency to monitor patients at home, but there is a lack of robust data comparing the technical success rates between the home and inpatient setting of PtcCO2 monitoring. The primary aim of the current study was to evaluate the rate of successful nocturnal PtcCO2 monitoring in a home setting in a population of patients with chronic hypercapnic respiratory failure receiving LT-NIV. The secondary aim was to compare these data with PtcCO2 registrations performed during regular follow up of a similar population of patients in a hospital setting.

Conditions

  • Type 2 Respiratory Failure
  • Hypercapnic Respiratory Failure

Interventions

DIAGNOSTIC_TEST

Transcutaneous CO2 monitoring

Transuctaneous CO2 monitoring

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER

  • University of Oslo

    lead OTHER

Principal Investigators

  • Sigurd Aarrestad, Dr.med · Oslo University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06694870 on ClinicalTrials.gov